• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌细胞中时间依赖性微小RNA表达的差异

Differences of time-dependent microRNA expressions in breast cancer cells.

作者信息

Bozkurt Serife Buket, Ozturk Bahadir, Kocak Nadir, Unlu Ali

机构信息

University of Selcuk, Faculty of Medicine, Department of Medical Biochemistry, Konya, Turkey.

Hacettepe University, Research Center of Dental Faculty, Ankara, Turkey.

出版信息

Noncoding RNA Res. 2020 Dec 19;6(1):15-22. doi: 10.1016/j.ncrna.2020.12.001. eCollection 2021 Mar.

DOI:10.1016/j.ncrna.2020.12.001
PMID:33385103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7770513/
Abstract

MicroRNA (miRNA) expression is a dynamic process in the cell, and the proper time period for post-transcriptional regulation might be critical due to the gene-on/-off expression times of the cell. Here, we investigated the effect of different time-points on proliferation, invasion and miRNA expression profiles of human breast cancer cell lines MCF-7 (non-metastatic, epithelium-like breast cancer cell line with oestrogen receptor (ER) positive (+) and human breast cancer cell lines MDA-MB-435 (metastatic, invasive, ER negative (-). For this purpose, MCF-7 and MDA-MB-435 cells were seeded different number in E-plate 16 for proliferation experiment using an electrical impedance-based real-time cell analyzer system (RTCA) for 168 h. Similarly, invasion potential of MCF-7 and MDA-MB-435 were determined by RTCA for 90 h. Total RNAs including miRNAs were isolated at 2, 4, 6, 12, 24, 48 h from the MCF-7 and MDA-MB-435 cells. Afterward, the quantitative 84 miRNA expressions of MCF-7 and MDA-MB-435 were analyzed by Fluidigm Microfluidic 96.96 Dynamic Array. The results of these study demonstrated that both proliferation potential and invasion capacity of MDA-MB-435 is higher than MCF-7 as time-dependent manner. Furthermore, we detected that up/down expressions of 32 miRNAs at all time points in MDA-MB-435 compared to MCF-7 (at least ten-fold increased). Because of the high number of miRNAs, we more closely evaluated the expression of six of them (miR-100-5p, miR-29a-3p, miR-130a-3p, miR-10a-5p, miR-10b-5p, miR-203a), and determined that their levels were dramatically changed by at least 50-fold at different time points of the experiment (p < 0.01). The expression levels of five of these miRNAs (miR-100-5p, miR-10a-5p, miR-10b-5p, miR-130a-3p, and miR-29a-3p) started to increase from the fourth hour and continued to increase until the 48th hour in MDA-MB-435 cells compared to MCF-7 cells (p < 0.01). Simultaneously, the expression of one of these miRNAs (miR-203a) decreased from the sixth hour to the 48th hour in MDA-MB-435 as compared to MCF-7. We determined pathways associated with target genes using mirPath - DIANA TOOLS. Small RNAs including miRNA are essential regulatory molecules for gene expressions. In the literature, gene expressions have been published as burst and pulse in the form of discontinuous transcription. The data of the research suggested that time-dependent changes of miRNA expressions can be affected target gene transcriptional fluctuations in breast cancer cell and can be base for the further studies.

摘要

微小RNA(miRNA)表达是细胞中的一个动态过程,由于细胞的基因开启/关闭表达时间,转录后调控的合适时间段可能至关重要。在此,我们研究了不同时间点对人乳腺癌细胞系MCF-7(非转移性、上皮样乳腺癌细胞系,雌激素受体(ER)阳性(+))和人乳腺癌细胞系MDA-MB-435(转移性、侵袭性、ER阴性(-))增殖、侵袭及miRNA表达谱的影响。为此,将不同数量的MCF-7和MDA-MB-435细胞接种于E-plate 16中,使用基于电阻抗的实时细胞分析仪系统(RTCA)进行168小时的增殖实验。同样,使用RTCA测定MCF-7和MDA-MB-435的侵袭潜能,时长为90小时。在2、4、6、12、24、48小时从MCF-7和MDA-MB-435细胞中分离包括miRNA在内的总RNA。随后,通过Fluidigm微流控96.96动态阵列分析MCF-7和MDA-MB-435的84种miRNA定量表达。这些研究结果表明,MDA-MB-435的增殖潜能和侵袭能力均高于MCF-7,且呈时间依赖性。此外,我们检测到与MCF-7相比,MDA-MB-435在所有时间点均有32种miRNA的上调/下调表达(至少增加10倍)。由于miRNA数量众多,我们更深入地评估了其中6种(miR-100-5p、miR-29a-3p、miR-130a-3p、miR-10a-5p、miR-10b-�p、miR-203a)的表达,并确定在实验的不同时间点它们的水平至少有50倍的显著变化(p < 0.01)。与MCF-7细胞相比,MDA-MB-435细胞中这5种miRNA(miR-100-5p、miR-10a-5p、miR-10b-5p、miR-130a-3p和miR-29a-3p)的表达水平从第4小时开始升高,并持续升高至第48小时(p < 0.01)。同时,与MCF-7相比,MDA-MB-435中这些miRNA之一(miR-203a)的表达从第6小时至第48小时下降。我们使用mirPath - DIANA TOOLS确定了与靶基因相关的途径。包括miRNA在内的小RNA是基因表达的重要调控分子。在文献中,基因表达已以不连续转录的爆发和脉冲形式发表。该研究数据表明,miRNA表达的时间依赖性变化可能影响乳腺癌细胞中的靶基因转录波动,并可为进一步研究提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/ca553a3dfe59/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/154fc4e5f6ce/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/8f4d96fa7e00/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/ad2644c53bb0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/13f8e54ad019/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/ca553a3dfe59/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/154fc4e5f6ce/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/8f4d96fa7e00/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/ad2644c53bb0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/13f8e54ad019/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/7770513/ca553a3dfe59/gr5.jpg

相似文献

1
Differences of time-dependent microRNA expressions in breast cancer cells.乳腺癌细胞中时间依赖性微小RNA表达的差异
Noncoding RNA Res. 2020 Dec 19;6(1):15-22. doi: 10.1016/j.ncrna.2020.12.001. eCollection 2021 Mar.
2
Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.顺铂耐药 MDA-MB-231 细胞来源的外泌体以依赖外泌体 miR-423-5p 的方式增加受体细胞的耐药性。
Curr Drug Metab. 2019;20(10):804-814. doi: 10.2174/1389200220666190819151946.
3
MicroRNA expression profiles associated with the metastatic ability of MDA‑MB‑231 breast cancer cells.与MDA-MB-231乳腺癌细胞转移能力相关的微小RNA表达谱
Oncol Lett. 2023 Jun 22;26(2):339. doi: 10.3892/ol.2023.13926. eCollection 2023 Aug.
4
Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.雌激素受体阳性和阴性乳腺癌细胞系中miRNA-mRNA-lncRNA网络的分析
J Cell Mol Med. 2015 Dec;19(12):2874-87. doi: 10.1111/jcmm.12681. Epub 2015 Sep 28.
5
MiRNA-10b sponge: An anti-breast cancer study in vitro.微小RNA-10b海绵:一项体外抗乳腺癌研究
Oncol Rep. 2016 Apr;35(4):1950-8. doi: 10.3892/or.2016.4596. Epub 2016 Jan 26.
6
MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.miR-125a-5p 通过靶向 GAB2 抑制乳腺癌细胞的增殖和侵袭并诱导细胞凋亡。
Math Biosci Eng. 2019 Jul 29;16(6):6923-6933. doi: 10.3934/mbe.2019347.
7
MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.微小RNA-3646通过GSK-3β/β-连环蛋白信号通路导致人乳腺癌细胞对多西他赛耐药。
PLoS One. 2016 Apr 5;11(4):e0153194. doi: 10.1371/journal.pone.0153194. eCollection 2016.
8
Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.Caprin-1 是一种新型的 microRNA-223 靶标,可调节人乳腺癌细胞的增殖和侵袭。
Biomed Pharmacother. 2013 Sep;67(7):629-36. doi: 10.1016/j.biopha.2013.06.006. Epub 2013 Jul 12.
9
MicroRNA-16-5p overexpression suppresses proliferation and invasion as well as triggers apoptosis by targeting VEGFA expression in breast carcinoma.微小RNA-16-5p过表达通过靶向乳腺癌中的血管内皮生长因子A(VEGFA)表达来抑制增殖和侵袭,并引发细胞凋亡。
Oncotarget. 2017 Aug 23;8(42):72400-72410. doi: 10.18632/oncotarget.20398. eCollection 2017 Sep 22.
10
MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.miR-339-5p 抑制体外乳腺癌细胞迁移和侵袭,可能成为乳腺癌预后的潜在生物标志物。
BMC Cancer. 2010 Oct 9;10:542. doi: 10.1186/1471-2407-10-542.

引用本文的文献

1
Shedding Light on the Molecular Diversities of miRNA in Cancer- an Exquisite Mini Review.揭示癌症中miRNA的分子多样性——一篇精妙的小型综述
Mol Biotechnol. 2024 Nov 4. doi: 10.1007/s12033-024-01312-5.
2
Exploring the time-dependent regulatory potential of microRNAs in breast cancer cells treated with proteasome inhibitors.探讨蛋白酶体抑制剂处理的乳腺癌细胞中 microRNAs 的时变调控潜力。
Clin Transl Oncol. 2024 May;26(5):1256-1267. doi: 10.1007/s12094-023-03349-5. Epub 2023 Dec 1.
3
Molecular and Cellular Mechanism of Action of Chrysotile Asbestos in MRC5 Cell Line.

本文引用的文献

1
circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis.环状 RNA TADA2A 通过靶向 miR-203a-3p/SOCS3 轴抑制乳腺癌的进展和转移。
Cell Death Dis. 2019 Feb 20;10(3):175. doi: 10.1038/s41419-019-1382-y.
2
MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells.MYC诱导的miR-203b-3p和miR-203a-3p调控肿瘤细胞中Bcl-xL的表达及对紫杉醇的敏感性。
Transl Oncol. 2019 Jan;12(1):170-179. doi: 10.1016/j.tranon.2018.10.001. Epub 2018 Oct 22.
3
MicroRNA.
温石棉在MRC5细胞系中的分子与细胞作用机制
J Pers Med. 2023 Nov 12;13(11):1599. doi: 10.3390/jpm13111599.
4
Expression Profiling of Adipogenic and Anti-Adipogenic MicroRNA Sequences following Methylmercury Exposure in .甲基汞暴露后脂肪生成和抗脂肪生成微小RNA序列的表达谱分析
Toxics. 2023 Nov 17;11(11):934. doi: 10.3390/toxics11110934.
5
Identification of MicroRNAs Associated with Prediabetic Status in Obese Women.鉴定肥胖女性糖尿病前期状态相关的 microRNAs。
Int J Mol Sci. 2023 Oct 27;24(21):15673. doi: 10.3390/ijms242115673.
6
In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer.乳腺癌中CDK4/6治疗下的体外微小RNA表达谱改变
Biomedicines. 2023 Oct 5;11(10):2705. doi: 10.3390/biomedicines11102705.
微小 RNA
J Allergy Clin Immunol. 2018 Apr;141(4):1202-1207. doi: 10.1016/j.jaci.2017.08.034. Epub 2017 Oct 23.
4
MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.微小 RNA-130b 通过 PI3K/Akt 信号通路靶向 PTEN 介导乳腺癌细胞的耐药性和增殖。
Sci Rep. 2017 Feb 6;7:41942. doi: 10.1038/srep41942.
5
Intracellular and extracellular microRNA: An update on localization and biological role.细胞内和细胞外微小RNA:定位与生物学作用的最新进展
Prog Histochem Cytochem. 2016 Nov;51(3-4):33-49. doi: 10.1016/j.proghi.2016.06.001. Epub 2016 Jun 25.
6
Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer.分子检测与病理学家在乳腺癌临床试验中的作用。
Clin Breast Cancer. 2016 Jun;16(3):166-79. doi: 10.1016/j.clbc.2016.02.016. Epub 2016 Feb 12.
7
Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.miR-10b通过下调HDAC4在雌激素受体阳性乳腺癌细胞的他莫昔芬耐药中的功能作用
BMC Cancer. 2015 Jul 24;15:540. doi: 10.1186/s12885-015-1561-x.
8
MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.乳腺癌中对阿霉素治疗反应的微小RNA谱
J Cell Biochem. 2015 Sep;116(9):2061-73. doi: 10.1002/jcb.25162.
9
Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.miR-100在癌症诊断、预后及治疗中的潜在作用。
Tumour Biol. 2015 Mar;36(3):1403-9. doi: 10.1007/s13277-015-3267-8. Epub 2015 Mar 5.
10
MicroRNA 130b enhances drug resistance in human ovarian cancer cells.微小RNA 130b增强人卵巢癌细胞的耐药性。
Tumour Biol. 2014 Dec;35(12):12151-6. doi: 10.1007/s13277-014-2520-x. Epub 2014 Aug 26.